FDA.reportPublic FDA data

Haemoglobin F (HbF) IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative determination of haemoglobin subtype F (HbF), also known as foetal haemoglobin, in a clinical specimen.
GUDID devices
14
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
08719327450949Anti-HbF PUREIQ Products B.V.IQP-567P2023-01-26
08719327450956Anti-HbF FITCIQ Products B.V.IQP-567F2023-01-26
08719327450963Anti-HbF R-PEIQ Products B.V.IQP-567R2023-01-26
08719327450970Anti-HbF Dy-410IQ Products B.V.IQP-567D2023-01-26
08721264790002Anti-HbF R-PEIQ Products B.V.IQP-578R2024-11-13
04054839149092Fetal HemoglobinSigma-Aldrich, Inc.285C-1KT2016-09-16
04054839149108Fetal HemoglobinSigma-Aldrich, Inc.285D-1KT2016-09-16
04560189283503G7 Beta-Thalassemia Elution Buffer KitTOSOH CORPORATIONN/A2016-09-24
00847817008610VARIANT II B-thalassemiaBIO-RAD LABORATORIES, INC.270-00042016-09-12
00851318008000Simmler, Inc.SIMMLER INCS0412-002017-10-19
00851318008017Simmler, Inc.SIMMLER INCS0412-1002017-10-19
00851318008024Simmler, Inc.SIMMLER INCS0412A-1002017-10-19
00851318008031Simmler, Inc.SIMMLER INCS0411-062017-10-19
00851318008048Simmler, Inc.SIMMLER INCS0412C2017-10-19